|
|
|
|
|
|
|
|
|
12.08.26 - 13:33
|
InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001 (Business Wire)
|
|
|
IDP-001 is a bispecific antibody-drug conjugate targeting EGFR and a novel Tumor-Associated Proximity Antigen identified through InduPro's proximity-guided platform
Phase 1 study is enrolling adults with advanced squamous non-small cell lung cancer and other solid tumors
Financing led by The Column Group, with participation from Vida Ventures, MRL Ventures Fund, Emerson Collective (advised by Yosemite), Euclidean Capital, Solasta Ventures, Sanofi, and Eli Lilly and CompanySEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, today announced the closing of a $77 million Series B financing and the dosing of the first patient in the Phase 1 clinical study of IDP-001, the company's lead oncology program.
Proceeds from the financing will support Phase 1 clinical development and generation of early proof-of-concept data for IDP-001, as well as the adva...
|
|
|
|
|
10.08.26 - 19:03
|
Andersen Accelerates Global Expansion with Six Acquisitions in Mexico and the United States (Business Wire)
|
|
|
Deals Add Approximately $34.5 Million in Annualized Revenue, Strengthening Andersen's Integrated Professional Services Platform and Expanding Andersen ConsultingSAN FRANCISCO--(BUSINESS WIRE)--Andersen Group Inc. (NYSE: ANDG), one of the fastest-growing global professional services firms, today announced the acquisition of Andersen Mexico, a leading tax and legal firm, along with five U.S.-based Andersen Consulting firms—Clareon, BD Emerson, Daniels Consulting Group, Endeavor Management and Zenger Folkman—further strengthening its integrated, multi-dimensional professional services platform while accelerating the growth of Andersen Consulting.
The transactions are expected to contribute approximately $34.5 million in annualized revenue, increasing the total annualized revenue from acquisitions announced since Andersen's first quarter update to approximately $67 million.
The acquisition of Andersen Mexico expands Andersen's presence in one of North America's most important markets, strengthening th...
|
|
|
|
|
|
|
05.08.26 - 14:36
|
Glucotrack Announces $5.5 Million Financing (Business Wire)
|
|
|
Includes $2.0 Million Equity Financing at $0.75 Per Unit, priced at a premium to the market, and $3.5 Million Follow-On Investment from Institutional InvestorsRUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (NASDAQ: GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for approximately $5.5 million in financing from participating institutional investors, including a $2.0 million equity financing priced at $0.75 per unit and a $3.5 million follow-on investment in the form of convertible debt.
The equity financing consists of units priced at $0.75 per unit, with each unit comprised of one share of common stock (or equivalent) and one five-year warrant with an exercise price of $1.50 per share.
"We believe one of the strongest signals investors can send is choosing to increase their alignment with common shareholders," said Erik Emerson, Chief Executive Officer of Glucotrack. "This financing strengthens our balance sheet, provid...
|
|
|
|
|
|
|
|
|
|
|
|
|
04.08.26 - 22:37
|
Emerson Electric Co. Q3 Profit Climbs (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Emerson Electric Co. (EMR) released earnings for its third quarter that Increases, from the same period last yearThe company's bottom line totaled $718 million, or $1.28 per......
|
|
|
|
|
|
|
04.08.26 - 22:09
|
Emerson Reports Third Quarter 2026 Results; Raises 2026 Outlook (PR Newswire)
|
|
|
ST. LOUIS, Aug. 4, 2026 /PRNewswire/ -- Emerson (NYSE: EMR) today reported results1 for its third quarter ended June 30, 2026 and updated its full year outlook for fiscal 2026. Emerson also declared a quarterly cash dividend of $0.555 per share of common stock payable September 10, 2026......
|
|
|
|
|
|